dc.creatorLapiere, Alexia
dc.creatorGeiger, Mallia
dc.creatorRobert, Véronique
dc.creatorDemarquay, Christelle
dc.creatorAuger, Sandrine
dc.creatorChadi, Sead
dc.creatorBenadjaou, Mohamedamine
dc.creatorFernandes, Gabriel da Rocha
dc.creatorMilliat, Fabien
dc.creatorLangell, Philippe
dc.creatorBenderitter, Marc
dc.creatorChatel, Jean-Marc
dc.creatorSémont, Alexandra
dc.date2023-05-22T17:47:31Z
dc.date2023-05-22T17:47:31Z
dc.date2020
dc.date.accessioned2023-09-26T20:59:58Z
dc.date.available2023-09-26T20:59:58Z
dc.identifierLAPIERE, Alexia et al. Prophylactic Faecalibacterium prausnitzii treatment prevents the acute breakdown of colonic epithelial barrier in a preclinical model of pelvic radiation disease. Gut Microbes, v. 12, n. 1), 1812867, 2020. doi: 10.1080/19490976.2020.1812867.
dc.identifier1949-0976
dc.identifierhttps://www.arca.fiocruz.br/handle/icict/58557
dc.identifier10.1080/19490976.2020.1812867
dc.identifier.urihttps://repositorioslatinoamericanos.uchile.cl/handle/2250/8867491
dc.descriptionEvery year, millions of people around the world benefit from radiation therapy to treat cancers localized in the pelvic area. Damage to healthy tissue in the radiation field can cause undesirable toxic effects leading to gastrointestinal complications called pelvic radiation disease. A change in the composition and/or function of the microbiota could contribute to radiation-induced gastrointestinal toxicity. In this study, we tested the prophylactic effect of a new generation of probiotic likeFaecalibacterium prausnitzii(F. prausnitzii) on acute radiation-induced colonic lesions. Experiments were carried out in a preclinical model of pelvic radiation disease. Rats were locally irradiated at 29 Gray in the colon resulting in colonic epithelial barrier rupture. Three days before the irradiation and up to 3 d after the irradiation, theF. prausnitziiA2-165 strain was administered daily (intragastrically) to test its putative protective effects. Results showed that prophylacticF. prausnitziitreatment limits radiation-induced para-cellular hyperpermeability, as well as the infiltration of neutrophils (MPO+ cells) in the colonic mucosa. Moreover,F. prausnitziitreatment reduced the severity of the morphological change of crypts, but also preserved the pool of Sox-9+ stem/progenitor cells, the proliferating epithelial PCNA+ crypt cells and the Dclk1+/IL-25+ differentiated epithelial tuft cells. The benefit ofF. prausnitziiwas associated with increased production of IL-18 by colonic crypt epithelial cells. Thus,F. prausnitziitreatment protected the epithelial colonic barrier from colorectal irradiation. New-generation probiotics may be promising prophylactic treatments to reduce acute side effects in patients treated with radiation therapy and may improve their quality of life.
dc.description2099-12-31
dc.formatapplication/pdf
dc.languageeng
dc.publisherTaylor & Francis
dc.rightsrestricted access
dc.subjectprophylactic treatment
dc.subjectFaecalibacterium prausnitzii
dc.subjectpelvic radiation disease
dc.subjectcolonic epithelial barrier
dc.subjectinflammation
dc.subjecttuft cells
dc.titleProphylactic Faecalibacterium prausnitzii treatment prevents the acute breakdown of colonic epithelial barrier in a preclinical model of pelvic radiation disease
dc.typeArticle


Este ítem pertenece a la siguiente institución